The COVID-19 pandemic has sparked an increase in focus and use of telemedicine in several patient care settings. This survey study was distributed to actively practicing US-based physicians and examines telehealth use 2 years after the beginning of the COVID pandemic from a physician’s perspective. Notable findings include telehealth benefits which include increased patient access and the ability to work from home. A continued drawback in telehealth visits is the limitations on a complete physical examination, a drawback that was emphasized by the dermatology community. While this study sheds light on the developing nature of telehealth, it is limited by its retrospective nature and sample size. Future research with larger sample sizes focusing on economic incentives and telemedicine training may help to overcome barriers to using telehealth. J Drugs Dermatol. 2023;22(11):e4-e8 doi:10.36849/JDD.7386e.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.36849/JDD.7386 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!